Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,503,000 | 1,521,000 | 1,715,000 | 1,761,000 | 1,296,000 |
| Marketable Securities | N/A | N/A | N/A | 1,650,000 | 1,603,000 |
| Receivables | 1,280,000 | 1,031,000 | 1,152,000 | 1,046,000 | 998,000 |
| Inventories | 18,000 | 21,000 | 18,000 | 14,000 | 13,000 |
| TOTAL | $2,801,000 | $2,573,000 | $2,885,000 | $4,471,000 | $3,910,000 |
| Non-Current Assets | |||||
| PPE Net | 137,000 | 143,000 | 153,000 | 145,000 | 152,000 |
| Investments And Advances | 36,000 | 40,000 | 37,000 | 36,000 | 35,000 |
| Intangibles | 9,227,000 | 9,303,000 | 9,478,000 | 2,103,000 | 2,107,000 |
| Other Non-Current Assets | 314,000 | 317,000 | 320,000 | 266,000 | 260,000 |
| TOTAL | $9,714,000 | $9,803,000 | $9,988,000 | $2,550,000 | $2,554,000 |
| Total Assets | $12,515,000 | $12,376,000 | $12,873,000 | $7,021,000 | $6,464,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 294,000 | 275,000 | 273,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 807,000 | 861,000 | 1,069,000 | 602,000 | 567,000 |
| Other current liabilities | 21,000 | 24,000 | 24,000 | 3,000 | 6,000 |
| TOTAL | $1,140,000 | $1,178,000 | $1,427,000 | $741,000 | $629,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,841,000 | 4,933,000 | 5,001,000 | N/A | N/A |
| Other Non-Current Liabilities | 213,000 | 218,000 | 234,000 | 199,000 | 203,000 |
| TOTAL | $5,418,000 | $5,516,000 | $5,599,000 | $529,000 | $533,000 |
| Total Liabilities | $6,558,000 | $6,694,000 | $7,026,000 | $1,270,000 | $1,162,000 |
| Shareholders' Equity | |||||
| Common Shares | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| Retained earnings | 4,421,000 | 4,090,000 | 4,098,000 | 4,032,000 | 3,598,000 |
| Other shareholders' equity | -397,000 | -340,000 | -181,000 | -204,000 | -210,000 |
| TOTAL | $5,957,000 | $5,682,000 | $5,847,000 | $5,751,000 | $5,302,000 |
| Total Liabilities And Equity | $12,515,000 | $12,376,000 | $12,873,000 | $7,021,000 | $6,464,000 |